Supriya Lifescience Ltd (SUPRIYA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003587, "name": "Supriya Lifesci.", "stock_name": "Supriya Lifesci.", "full_name": "Supriya Lifescience Ltd", "name_url": "stocks-analysis/supriya-lifesci", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "577.60", "chg": -7.7, "chgp": "-1.32%", "dir": -1, "prev_price": "585.30", "mcapval": "4,828.00 Cr", "mcap": "Small Cap", "scripcode": 543434, "symbol": "SUPRIYA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE07RO01027", "curr_date": "Mar 13", "curr_time": "", "bse_nse_vol": "2.71 lacs", "exc_status": "Active", "traded_date": "Mar 13, 2026", "traded_date_str": "2026 03 13", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Supriya Lifescience Drops 7.85% Amid 52-Week Low and Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-drops-785-amid-52-week-low-and-market-volatility-3890577", "imagepath": "", "date": "2026-03-14 10:05:22", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 9:</strong> New 52-week low (Rs.573.45)</p>\n <p><strong>Mar 10:</strong> Partial recovery to Rs.604.75 (+4.09%)</p>\n <p><strong>Mar 11-13:</strong> Consecutive declines ending at Rs.577.55 (-0.31% on last day)</p>\n <p><strong>Weekly Summary:</strong> Stock closed down 7.85% vs Sensex down 4.87%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.626.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.577.55</div><div class=\"st..." }, { "title": "Supriya Lifescience Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-is-rated-sell-3888421", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SupriyaLifescie_mojoScore_3888421.png", "date": "2026-03-13 10:10:29", "description": "Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Supriya Lifescience Ltd Stock Falls to 52-Week Low Amid Market Downturn", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-stock-falls-to-52-week-low-amid-market-downturn-3880314", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SupriyaLifescie_priceRelatedfactors_3880314.png", "date": "2026-03-09 13:58:08", "description": "Supriya Lifescience Ltd’s stock declined sharply today, hitting a new 52-week low of Rs.573.45. This drop comes amid broader market weakness and follows two days of gains, marking a notable reversal in the stock’s recent trend." }, { "title": "Supriya Lifescience Ltd Hits Intraday Low Amid Price Pressure on 9 Mar 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-low-amid-price-pressure-on-9-mar-2026-3879630", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SupriyaLifescie_priceRelatedfactors_3879630.png", "date": "2026-03-09 10:01:04", "description": "Supriya Lifescience Ltd witnessed a significant intraday decline on 9 Mar 2026, touching a new 52-week low of Rs 579.9 as the stock faced pronounced selling pressure, underperforming its sector and broader market indices amid a generally weak market environment." }, { "title": "Supriya Lifescience Falls 4.07%: Technical Downgrade and Valuation Concerns Weigh", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-falls-407-technical-downgrade-and-valuation-concerns-weigh-3878104", "imagepath": "", "date": "2026-03-07 12:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Mar:</strong> Downgrade to Sell rating announced amid bearish technicals</p>\n <p><strong>2 Mar:</strong> Stock closes at ₹637.70, down 2.40% on heavy selling pressure</p>\n <p><strong>4 Mar:</strong> Continued decline to ₹619.35, down 2.88% amid weak market conditions</p>\n <p><strong>5 Mar:</strong> Minor recovery to ₹624.50, up 0.83% as Sensex rallies</p>\n <p><strong>6 Mar:</strong> Week closes at ₹626.75, slight gain of 0.36% on volatile session</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class..." }, { "title": "Supriya Lifescience Ltd Downgraded to Sell Amid Bearish Technicals and Valuation Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-downgraded-to-sell-amid-bearish-technicals-and-valuation-concerns-3863648", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SupriyaLifescie_mojoScore_3863648.png", "date": "2026-03-02 08:10:36", "description": "Supriya Lifescience Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 27 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat recent financial performance, and subdued long-term growth prospects. The company’s Mojo Score now stands at 38.0, with a Mojo Grade of Sell, signalling caution for investors amid a challenging market environment." }, { "title": "Supriya Lifescience Ltd Faces Bearish Momentum Amid Technical Downgrade", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-faces-bearish-momentum-amid-technical-downgrade-3863601", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SupriyaLifescie_technicaldot_3863601.png", "date": "2026-03-02 08:02:50", "description": "Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a bearish stance. This change is underscored by a series of technical indicators signalling increased selling pressure, with the stock currently trading at ₹653.00, down 1.51% from its previous close of ₹663.00. Investors are advised to carefully analyse these developments amid a broader market context where the Sensex has outperformed the stock over recent periods." }, { "title": "Supriya Lifescience Declines 3.53%: Death Cross and Mixed Signals Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-declines-353-death-cross-and-mixed-signals-shape-the-week-3862210", "imagepath": "", "date": "2026-02-28 11:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Feb:</strong> Technical momentum shifts to sideways trend amid mixed indicators</p>\n <p><strong>27 Feb:</strong> Death Cross formation signals bearish trend ahead</p>\n <p><strong>27 Feb:</strong> Week closes at Rs.653.35, down 3.53%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.677.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.653.35</div><div class=\"stat-change negative\">-3.53%</div></div>\n <div class=\"stat-item\"><..." }, { "title": "Supriya Lifescience Ltd Forms Death Cross, Signalling Bearish Trend Ahead", "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-forms-death-cross-signalling-bearish-trend-ahead-3860607", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SupriyaLifescie_dealthcross_3860607.png", "date": "2026-02-27 18:05:14", "description": "Supriya Lifescience Ltd has recently experienced a significant technical development as its 50-day moving average (DMA) crossed below the 200-day moving average, forming a Death Cross. This event is widely regarded by market analysts as a bearish signal, indicating a potential deterioration in the stock’s trend and raising concerns about its medium to long-term price prospects." } ], "total": 294, "sid": "1003587", "stock_news_url": "https://www.marketsmojo.com/news/supriya-lifescience-1003587" }, "announcements": [ { "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot", "datetime": "10-Mar-2026", "details": "Please find attached Postal Ballot Notice of Supriya Lifescience Limited.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "17-Feb-2026", "details": "Transcript of the Earnings Call for the Unaudited Financial Results for quarter and nine months ended December 31 2025 is enclosed herewith. Kindly take the same on record.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome", "datetime": "10-Feb-2026", "details": "Audio Recording of the Earnings Call for Unaudited Financial Results of quarter and nine months ended December 31 2025 is enclosed herewith.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 25", "dt": "2025-09-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 9: New 52-week low (Rs.573.45)

Mar 10: Partial recovery to Rs.604.75 (+4.09%)

Mar 11-13: Consecutive declines ending at Rs.577.55 (-0.31% on last day)

Weekly Summary: Stock closed down 7.85% vs Sensex down 4.87%

Read full news article

Supriya Lifescience Ltd is Rated Sell

2026-03-13 10:10:29

Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Supriya Lifescience Ltd Stock Falls to 52-Week Low Amid Market Downturn

2026-03-09 13:58:08

Supriya Lifescience Ltd’s stock declined sharply today, hitting a new 52-week low of Rs.573.45. This drop comes amid broader market weakness and follows two days of gains, marking a notable reversal in the stock’s recent trend.

Read full news article

Supriya Lifescience Ltd Hits Intraday Low Amid Price Pressure on 9 Mar 2026

2026-03-09 10:01:04

Supriya Lifescience Ltd witnessed a significant intraday decline on 9 Mar 2026, touching a new 52-week low of Rs 579.9 as the stock faced pronounced selling pressure, underperforming its sector and broader market indices amid a generally weak market environment.

Read full news article

Supriya Lifescience Falls 4.07%: Technical Downgrade and Valuation Concerns Weigh

2026-03-07 12:00:05

Key Events This Week

2 Mar: Downgrade to Sell rating announced amid bearish technicals

2 Mar: Stock closes at ₹637.70, down 2.40% on heavy selling pressure

4 Mar: Continued decline to ₹619.35, down 2.88% amid weak market conditions

5 Mar: Minor recovery to ₹624.50, up 0.83% as Sensex rallies

6 Mar: Week closes at ₹626.75, slight gain of 0.36% on volatile session

Week Open

Read full news article

Supriya Lifescience Ltd Downgraded to Sell Amid Bearish Technicals and Valuation Concerns

2026-03-02 08:10:36

Supriya Lifescience Ltd, a player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 27 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, flat recent financial performance, and subdued long-term growth prospects. The company’s Mojo Score now stands at 38.0, with a Mojo Grade of Sell, signalling caution for investors amid a challenging market environment.

Read full news article

Supriya Lifescience Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-03-02 08:02:50

Supriya Lifescience Ltd has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a bearish stance. This change is underscored by a series of technical indicators signalling increased selling pressure, with the stock currently trading at ₹653.00, down 1.51% from its previous close of ₹663.00. Investors are advised to carefully analyse these developments amid a broader market context where the Sensex has outperformed the stock over recent periods.

Read full news article

Supriya Lifescience Declines 3.53%: Death Cross and Mixed Signals Shape the Week

2026-02-28 11:00:05

Key Events This Week

23 Feb: Technical momentum shifts to sideways trend amid mixed indicators

27 Feb: Death Cross formation signals bearish trend ahead

27 Feb: Week closes at Rs.653.35, down 3.53%

Read full news article

Supriya Lifescience Ltd Forms Death Cross, Signalling Bearish Trend Ahead

2026-02-27 18:05:14

Supriya Lifescience Ltd has recently experienced a significant technical development as its 50-day moving average (DMA) crossed below the 200-day moving average, forming a Death Cross. This event is widely regarded by market analysts as a bearish signal, indicating a potential deterioration in the stock’s trend and raising concerns about its medium to long-term price prospects.

Read full news article

View All News